Coronation Fund Managers Ltd. Alnylam Pharmaceuticals, Inc. Transaction History

Coronation Fund Managers Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$93.12 - $133.99 $9.14 Million - $13.2 Million	-98,147 Closed	0 $0
Q4 2019 Jan 21, 2020	SELL	$74.51 - $124.23 $2.61 Million - $4.35 Million	-35,024 Reduced 26.3%	98,147 $11.3 Million
Q3 2019 Nov 01, 2019	SELL	$70.9 - $87.82 $3.29 Million - $4.08 Million	-46,439 Reduced 25.86%	133,171 $10.7 Million
Q2 2019 Jul 25, 2019	BUY	$65.86 - $92.79 $3.52 Million - $4.96 Million	53,460 Added 42.38%	179,610 $13 Million
Q1 2019 Apr 24, 2019	BUY	$72.76 - $93.45 $9.18 Million - $11.8 Million	126,150 New	126,150 $11.8 Million

650

109M

1.28M

1.23M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.4B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Coronation Fund Managers Ltd., based on Form 13F filings with the SEC.

Stay updated on Coronation Fund Managers Ltd. with notifications on news.